Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 food-effect study of DS-3201b in healthy subjects
jRCT2071200043Phase 1Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of valemetostat (2 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoints: Cmax of total DS-3201a, AUClast of total DS-3201a and 1 more. Started Oct 2020; status: completed.
02
Drugs
valemetostat
Beyond the preview
Go deeper on jRCT2071200043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071200043.